DUBLIN, September 25, 2017 /PRNewswire/ --
The "Allergy Diagnostics Market by Products (Assay Kits, Immunoassay & Elisa Analyzers, Luminometers, Services), Allergens (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End Users (Hospital, Diagnostic Laboratory) - Global Forecast to 2022" report has been added to Research and Markets' offering.
The global allergy diagnostics market is expected to reach USD 5.74 Billion by 2022 from USD 3.49 Billion in 2017, at a CAGR of 10.5%.
A number of factors, such as the high incidence and large economic burden of allergic diseases, rising environmental pollution levels, increasing healthcare expenditure, and growing access to medical insurance in the US are expected to drive the growth of this market.
The global allergy diagnostics market is segmented by product & service, test type, allergen, end user, and region. By product & service, the allergy diagnostics market is segmented into assay kits, instruments, and services. The assay kits segment is expected to lead the global allergy diagnostics market in 2017. The widespread availability and large consumption of assay kits in allergy testing are expected to drive the growth of this segment in the coming years.
The global allergy diagnostics systems market is dominated by North America, followed by Europe. North America will continue to dominate the global allergy diagnostics market during the forecast period. However, Asia is expected to witness the highest CAGR, with the growth in this market centered at Japan, China, and India. Improving life sciences research infrastructure in emerging economies and growing government investment in biomedical, pharmaceutical, and biotechnology industries are some factors propelling market growth in the Asian region.
The worldwide economic downturn and pricing limitations are expected to restrain the market growth to a certain extent.
Major industry players launched innovative products in the recent past and have plans to launch new products and expand across geographies via partnerships and acquisitions in the future. Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), and Siemens AG (Germany) have been identified as the top players in this market. These companies have a broad product portfolio with comprehensive features and have also launched innovative products. Further, these leaders have products for all end users in this segment, strong geographical presence, and more importantly focus on continuous product innovations.
Market Dynamics
Drivers
- High Incidence And Large Economic Burden of Allergic Diseases
- Rising Environmental Pollution Levels
- Increasing Healthcare Expenditure
- Increasing Access for Allergy Diagnosis Medical Insurance in the Us 37
Restraints
- Issues Related to the Affordability of Allergy Diagnostics Instruments Among Small Laboratories And Physician Clinics
- Low Awareness of Allergic Diseases
Opportunities
- Emerging Economies Across Asia And Row
Trends
- Growing Adoption of Automation for Quicker Turnaround Times
- Growth in the Number of Reagent Rental Agreements
Companies Mentioned
- Alk-Abell A/S (Denmark)
- Allergy Therapeutics (Uk)
- Angsana Molecular & Diagnostics Laboratory Pte Ltd
- Astra Biotech Gmbh (Germany)
- Biomrieux Sa
- Danaher Corporation
- Demeditec Diagnostics Gmbh (Germany)
- Dr. Fooke - Achterrath Laboratorien Gmbh (Germany)
- Dst Diagnostische Systeme & Technologien Gmbh (Germany)
- Euroimmun Ag (Germany)
- Ga Generic Assays Gmbh (Germany)
- Hal Allergy Group (Netherlands)
- Hitachi Chemical Co. Ltd.
- Hob Biotech Group Suzhou Co. Ltd.
- Hycor Biomedical Inc.
- Indoor Biotechnologies Inc. (Us)
- Lincoln Diagnostics Inc.
- Omega Diagnostics Group Plc
- R-Biopharm Ag
- Roxall Medical Gmbh (Germany)
- Siemens Ag
- Stallergenes Greer
- Tecan Trading Ag (Switzerland)
- Theradiag (France)
- Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/research/s7zdjz/allergy
Media Contact:
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Share this article